INTS Stock: Intensity Therapeutics, Inc. Stock Price, Analysis & Insights

Get live INTS stock price $3.71, comprehensive Intensity Therapeutics, Inc. stock analysis, charts, news, and expert forecast. Real-time INTS stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

3.71

1.85%Today

INTS • Intensity Therapeutics, Inc. • NASDAQ Capital Market • Healthcare

Market Cap

7.00M

Volume

39.95K

52W High

43.50

52W Low

3.51

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Intensity Therapeutics, Inc. is a biotechnology enterprise in the clinical development phase, dedicated to discovering, advancing, and commercializing pharmaceutical treatments for solid tumor cancers. The company's primary experimental compound, INT...

Contact Information

Website: https://www.intensitytherapeutics.com
Address: 61 Wilton Road
Country: US

Investment Analysis & Business Insights

Healthcare

Biotechnology

Investment Highlights

✓ Strong presence in the Healthcare sector with established market position

✓ Higher growth potential with elevated volatility (Beta: 3.06)

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for Intensity Therapeutics, Inc. shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Healthcare may affect company performance
⚠Past performance does not guarantee future results for Intensity Therapeutics, Inc.
⚠Investors should consider how Intensity Therapeutics, Inc. fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

7.00M

P/E Ratio (TTM)

-0.93

Beta

3.06

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare INTS with peer companies:

AN2 Therapeutics, Inc. (ANTX)

Price: $3.91
Market cap: 107.14M

Boundless Bio, Inc. (BOLD)

Price: $1.40
Market cap: 31.45M

iBio, Inc. (IBIO)

Price: $1.70
Market cap: 26.84M

Iterum Therapeutics plc (ITRM)

Price: $0.03
Market cap: 1.60M

NextCure, Inc. (NXTC)

Price: $2.33
Market cap: 6.24M

Pluri Inc. (PLUR)

Price: $2.38
Market cap: 21.40M

Plus Therapeutics, Inc. (PSTV)

Price: $5.50
Market cap: 13.31M

Q32 Bio Inc. (QTTB)

Price: $11.89
Market cap: 151.91M

Rallybio Corporation (RLYB)

Price: $15.91
Market cap: 84.29M

Sonnet BioTherapeutics Holdings, Inc. (SONN)

Price: $1.26
Market cap: 8.43M

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.